Natural Products: Review for Their Effects of Anti-HBV

被引:12
|
作者
Liu, Xuqiang [1 ,2 ]
Ma, Changyang [1 ]
Liu, Zhenhua [1 ]
Kang, Wenyi [1 ,2 ,3 ]
机构
[1] Henan Univ, Natl R&D Ctr Edible Fungus Proc Technol, Kaifeng 475004, Peoples R China
[2] Funct Food Engn Technol Res Ctr, Kaifeng 475004, Henan, Peoples R China
[3] Henan Univ, Joint Int Res Lab Food & Med Resource Funct, Kaifeng 475004, Henan, Peoples R China
关键词
B VIRUS ACTIVITY; SHIONANE-TYPE TRITERPENES; TRADITIONAL CHINESE HERB; HEPATITIS-B; ACTIVE CONSTITUENTS; CHEMICAL-CONSTITUENTS; ANTIVIRAL DRUGS; REPLICATION; COMPOUND; PROGRESS;
D O I
10.1155/2020/3972390
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis B is a global infectious disease, seriously endangering human health. Currently, there are mainly interferons and nucleoside analogues treatment of hepatitis B in the clinic, which have certain therapeutic effects on hepatitis B, but their side effects and drug resistance are increasingly prominent. Therefore, it is urgently needed to discover and develop new anti-HBV drugs, especially natural products, which have novel, high efficiency, and low toxicity anti-HBV compounds with novel antiviral mechanisms. In this manuscript, the natural products (polysaccharides and 165 compounds) with the activity of antihepatitis B virus are discussed according to their chemical classes, including 14 phenylpropanoids, 8 flavonoids,12 xanthones, 13 anthroquinones, 47 terpenoids, 6 alkaloids, 15 enediynes, 11 aromatics, 18 phenylalanine dipeptides compounds, and 13 others. In addition, the anti-HBV mechanism and targets of natural product were also discussed. The aim of this review is to report new discoveries about anti-HBV natural products and to provide reference for researchers.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Progress in Recent Study of Anti-HBV Natural Products and Extracts
    Li, Yantao
    Huang, Jianwei
    Xu, Ruian
    Cui, Xiuling
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2013, 10 (03) : 241 - 253
  • [2] Future anti-HBV strategies
    Gane, Edward J.
    LIVER INTERNATIONAL, 2017, 37 : 40 - 44
  • [3] Clevudine - Levovir - Anti-HBV
    不详
    DRUGS OF THE FUTURE, 2001, 26 (08) : 797 - 798
  • [4] DAPD - Anti-HIV - Anti-HBV
    不详
    DRUGS OF THE FUTURE, 2001, 26 (05) : 499 - 500
  • [5] DAPD -: Anti-HIV anti-HBV
    Furman, PA
    Cleary, D
    Trost, LC
    Bigley, JW
    Painter, GR
    DRUGS OF THE FUTURE, 2000, 25 (05) : 454 - 461
  • [6] Pharmacokinetics of Anti-HBV Polyoxometalate in Rats
    Wang, Juan
    Qu, Xiaofeng
    Qi, Yanfei
    Li, Jinhua
    Song, Xiuling
    Li, Li
    Yin, Dehui
    Xu, Kun
    Li, Juan
    PLOS ONE, 2014, 9 (06):
  • [7] ANTI-HBV CONSTITUENTS OF MEDICINAL PLANTS
    Chen, G. Y.
    Liu, M.
    Jiang, Z. G.
    Yu, M. B.
    Wei, S. C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 27 - 27
  • [8] Current status of anti-HBV chemotherapy
    Joon H. Hong
    Yongseok Choi
    Byoung K. Chun
    Kyeong Lee
    Chung K. Chu
    Archives of Pharmacal Research, 1998, 21 : 89 - 105
  • [9] Current status of anti-HBV chemotherapy
    Hong, JH
    Choi, YS
    Chun, BK
    Lee, K
    Chu, CK
    ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (02) : 89 - 105
  • [10] Anti-HBV nucleoside analogs.
    Bisacchi, GS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U313 - U313